Pregled bibliografske jedinice broj: 1182978
Characteristics and clinical outcomes of patients with acute gastrointestinal bleeding related to anticoagulant or antiplatelet therapy: a retrospective study
Characteristics and clinical outcomes of patients with acute gastrointestinal bleeding related to anticoagulant or antiplatelet therapy: a retrospective study // Croatian Medical Journal, 62 (2021), 5; 488-494 doi:10.3325/cmj.2021.62.488 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1182978 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Characteristics and clinical outcomes of patients
with acute gastrointestinal bleeding related to
anticoagulant or antiplatelet therapy: a
retrospective study
Autori
Božić, Dorotea ; Vuković, Jonatan ; Mustapić, Ivona ; Vrebalov Cindro, Pavle ; Božić, Joško ; Kardum, Goran ; Puljiz, Željko ; Tadin Hadjina, Ivana ; Tonkić, Ante
Izvornik
Croatian Medical Journal (0353-9504) 62
(2021), 5;
488-494
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
gastrointestinal bleeding, anticoagulant therapy, antiplatelet therapy
Sažetak
Aim: To investigate the demographic characteristics, endoscopic and laboratory findings, comorbidities and mortality rate of patients with gastrointestinal bleeding related to anticoagulant or antiplatelet therapy. Methods: We reviewed the records of patients admitted for gastrointestinal bleeding to the Intensive Care Unit of the Department of Gastroenterology, University Hospital Split, between 2015 and 2019. The characteristics and clinical outcomes of patients taking anticoagulant/antiplatelet therapy were analyzed. Results: The study enrolled 1367 patients, 434 (31.7%) of whom received anticoagulant/antiplatelet therapy (mean age 74.9±10.7 years ; 64.3% men). The most frequently prescribed drug was acetylsalicylic acid (56.7%), the most common bleeding site was the stomach (41.3%), and the most prevalent cause of bleeding was ulcer (61.6%). Patients taking anticoagulant/antiplatelet therapy who died had significantly higher creatinine (P=0.011) and lower albumin (P=0.015). In the multivariate analysis, the factors that negatively affected survival were older age, higher creatinine, and lower albumin. Patients taking anticoagulant/antiplatelet therapy had slightly lower in-hospital mortality (8.3%) compared with other patients (10.3%). Conclusion: Although anticoagulant/antiplatelet therapy increases the risk of gastrointestinal bleeding, it does not directly affect the outcome, which is mainly determined by age and comorbidities.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Filozofski fakultet u Splitu
Profili:
Ante Tonkić
(autor)
Jonatan Vuković
(autor)
Željko Puljiz
(autor)
Ivana Tadin Hađina
(autor)
Joško Božić
(autor)
Goran Kardum
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE